Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Brk, p Tyr342 Antibody, Novus Biologicals™
SDP

Catalog No. NB019429 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.025 mL
0.1 mL
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB019429 0.025 mL
NBP229687 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. NB019429 Supplier Novus Biologicals Supplier No. NBP2296870.025ML
Only null left
Add to Cart
Add to Cart

Rabbit Polyclonal Antibody

Brk Polyclonal specifically detects Brk in Human samples. It is validated for Western Blot.

Specifications

Antigen Brk (p Tyr342)
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Dilution Western Blot 1:100-1:2000
Formulation 0.1M Tris-Glycine (pH 7.4) and 0.15M NaCl with 0.05% Sodium Azide
Gene Accession No. Q13882
Gene Alias Breast tumor kinase, BRKprotein-tyrosine kinase 6, EC 2.7.10, EC 2.7.10.2, FLJ42088, protein-tyrosine kinase BRK, PTK6 protein tyrosine kinase 6, Tyrosine-protein kinase BRK
Gene Symbols PTK6
Host Species Rabbit
Immunogen KLH conjugated synthetic peptide corresponding to amino acids encompassing Tyr342 of human Brk.
Molecular Weight of Antigen 50 kDa
Purification Method Affinity Purified
Quantity 0.025 mL
Regulatory Status RUO
Research Discipline Protein Kinase
Primary or Secondary Primary
Gene ID (Entrez) 5753
Test Specificity Recognizes human phospho-Brk at tyrosine 342.
Target Species Human
Content And Storage Store at 4C. Do not freeze.
Isotype IgG
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.